Mark Aitkenhead, PhD

Chief Commercial Officer

Dr. Aitkenhead worked in a variety of leadership positions at Thermo Fisher Scientific since 2003, including most recently, General Manager for Cellular Analysis Instrumentation and Global Commercial Leader for the Clinical Next Generation Sequencing (NGS) Division. In the latter, he was accountable for the sales strategy and execution of the entire Ion Torrent NGS portfolio, a leading provider of clinical NGS instrumentation, assays, and consumables in oncology, applied, and research labs. During his tenure at Thermo Fisher, Dr. Aitkenhead also worked in technical and application support, field sales, and global customer care strategy. He received both his PhD in Anatomy and BMedSci in Biomedical Sciences from The Queen’s University of Belfast in Northern Ireland.